Clinical Study

Effectiveness and Safety of Concurrent Use of First-Line Antiretroviral and Antituberculous Drugs in Rwanda

Figure 1

(a) Percentage weight gain or loss observed. (b) Patients’ gain or loss in CD4 cells/mm3. (c) Physical improvement and death.
904957.fig.001a
(a)
904957.fig.001b
(b)
904957.fig.001c
(c)